IMS for OCT for Pharma
Reserach Use Only AI Models for 30+ Retinal Pathologies & 40+ Biomarkers for Pharma Studies
Free Trial without Calls
Explore Altris IMS
Explore the platform in a virtual demo or let us show it to you during the call
Free Trial
Virtual Demo
Altris IMS — Value for Pharmaceutical Professionals
✔️ Organize OCT data
✔️Access historical data
✔️Research Only AI Models
-
What ECPs think
-
"I am really happy with using Altris IMS in our research projects. And I was really impressed with the robustness of data."
-
Marta Shchur
Medical Director
"Altris IMS helps our eye care specialists to avoid mistakes and feel more confident with diagnostic decision-making. Definitely less guessing! Moreover, the examination goes faster so we can now have more patients."
-
Alisdair Buchanan
Optometry Owner
"Altris IMS has significantly enhanced the way we interpret OCT scans. What used to require prolonged focus and cross-referencing now takes moments, without sacrificing accuracy or depth. The system analyses images with incredible precision, highlighting subtle pathological changes which are often time-consuming to detect, especially during a busy clinic day."
-
Dr. Sundeep Kheterpal
Ophthalmic Surgeon
"We are very happy with the outstanding customer service and support."
For Innovative Pharma
Поддержка исследовательских процессов с помощью автоматизированного анализа изображений.
Помощь исследовательским группам в проверке данных ОКТ-изображений на соответствие критериям, определенным протоколом.
Настройка критериев отбора участников для каждого исследования.
Возможность создания настраиваемых, определяемых исследованием критериев фильтрации для анализа результатов.
Обеспечение согласованности в анализе данных изображений.
Предоставление автоматизированного анализа с использованием ИИ для поддержки стандартизированных и воспроизводимых исследовательских рабочих процессов.
Система поддержки принятия клинических решений на основе ИИ для анализа ОКТ в клиниках.
Помогает специалистам в области офтальмологии в обзоре, организации и визуализации данных ОКТ-изображений.
Поддержка идентификации соответствующих групп пациентов.
Предоставление информации о группах пациентов на основе характеристик изображений ОКТ в соответствии с утвержденными показаниями и маркировкой.
Предоставлять сводную аналитику для коммерческих команд.
Составлять высокоуровневые сводные отчеты по оценкам численности пациентов на уровне клиники или рынка.
Results in numbers
Our company was created in 2017 and we achieved many milestones since then
Let's talk
For Commercial Specialists
Support identification of patient cohorts based on OCT imaging characteristics, aligned with approved indications
Offer clear visualization and analysis of OCT imaging features across patient populations relevant to emerging treatment types
Enable retrospective analysis of OCT data from multiple manufacturers to support population-level insights
Provide access to aggregated real-world evidence (RWE) imaging data and longitudinal biomarker observations for analytical purposes
Support clinical workflows with AI-based decision support tools for reviewing and organizing OCT imaging data
For Clinical Researchers
Assist research teams in identifying potential study populations through OCT image analysis, in accordance with protocol-defined criteria
Support retrospective analysis of large volumes of OCT data from multiple manufacturers
Enable objective comparison of imaging-derived biomarkers across pre- and post-study timepoints for research and observational analysis
Configure study-specific filtering criteria to explore and query large OCT imaging datasets
Research
Running clinical studies shouldn’t be slowed down by manual processes or fragmented data
Contact Us- Supporting analysis of historical OCT data
- AI-enabled OCT image analysis
- Supporting protocol-defined patient review
- Supporting consistency and reproducibility
- Vendor-neutral OCT data access
- Supporting longitudinal imaging review
- Quantitative imaging outputs
Commercialization
Supporting transparency and data-driven insight across the drug commercialization process
Contact Us- Provide AI-based support for OCT image review
- Support understanding of patient populations
- Deliver transparent, aggregated insights on patient cohorts d
- Enable access to de-identified, observational real-world data
- Support educational initiatives for ECPs
- Provide data-informed analytics to support pharmaceutical commercialization activities
Medical Director